Document Detail

Intraventricular nerve growth factor infusion improves cerebral blood flow and stimulates doublecortin expression in two infants with hypoxic-ischemic brain injury.
MedLine Citation:
PMID:  18282376     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE AND IMPORTANCE: Hypoxic-ischemic brain injuries in childhood are associated with poor neurological outcome. Recently, experimental and clinical works show that nerve growth factor (NGF) reduces neurological deficits and promotes endothelial cells proliferation and angiogenesis following hypoxic-ischemic brain injuries. After brain stroke, new neurons express a protein, called doublecortin (DCX), which indicates a new marker for neurogenesis and migrating neuroblasts. This study investigates the effects of intraventricular NGF administration in two infants with severe hypoxic-ischemic brain damage and its role in both the cerebral perfusion and neurogenesis. CLINICAL PRESENTATION: Two infants, aged 8 and 13 months, with hypoxic-ischemic brain damage, secondary to prolonged cardiorespiratory arrest, were treated with intraventricular NGF administration. Before the therapy, both infants were comatose, aphasic and showed flaccid tetraparesis. After 1 month NGF treatment, their neurological conditions improved, electro-encephalography (EEG) examinations showed increased alpha/theta ratio, and single photon emission computed tomography (SPECT) works demonstrated a better cerebral perfusion. The DCX expression in the cerebrospinal fluid (CSF) increased concomitantly with increasing levels of NGF. INTERVENTION: The drug utilized was 2.5S NGF purified and lyophilized from male mouse submaxillary glands. The NGF administration was started 4 months after ischemic brain injury. NGF (0.1 mg) was administered via the external drainage catheter into the right cerebral ventricle once a day for 10 consecutive days. CONCLUSION: Our study shows that the intraventricular NGF administration improves the cerebral perfusion and stimulates the pathway of neurogenesis differentiation with the activation of DCX biosynthesis.
Antonio Chiaretti; Alessia Antonelli; Orazio Genovese; Eduardo Fernandez; DanielaDi Giuda; Paolo Mariotti; Riccardo Riccardi
Related Documents :
8777676 - Cerebral metabolic rate for glucose during the first six months of life: an fdg positro...
11245716 - Altered white and gray matter metabolism in cadasil: a proton mr spectroscopy and 1h-mr...
18759596 - Magnetic resonance imaging for quantitative flow measurement in infants with hydrocepha...
24856026 - Continuous renal replacement therapy in neonates and small infants: development and fir...
22633446 - The pilot study: sphingomyelin-fortified milk has a positive association with the neuro...
14562706 - The influence of a clear layer on near infrared spectrophotometry: comparison of measur...
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-02-15
Journal Detail:
Title:  Neurological research     Volume:  30     ISSN:  0161-6412     ISO Abbreviation:  Neurol. Res.     Publication Date:  2008 Apr 
Date Detail:
Created Date:  2008-04-25     Completed Date:  2008-08-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7905298     Medline TA:  Neurol Res     Country:  England    
Other Details:
Languages:  eng     Pagination:  223-8     Citation Subset:  IM    
Pediatric Intensive Care Unit, Catholic University Medical School, Rome, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cerebrovascular Circulation / drug effects*,  physiology
Gene Expression Regulation / drug effects*
Hypoxia-Ischemia, Brain / drug therapy*,  metabolism*,  pathology,  radionuclide imaging
Injections, Intraventricular / methods
Magnetic Resonance Imaging / methods
Microtubule-Associated Proteins / cerebrospinal fluid*
Nerve Growth Factor / administration & dosage*,  metabolism
Neurologic Examination
Neuropeptides / cerebrospinal fluid*
Submandibular Gland / chemistry
Time Factors
Tomography, Emission-Computed, Single-Photon / methods
Reg. No./Substance:
0/Microtubule-Associated Proteins; 0/Neuropeptides; 0/doublecortin protein; 9061-61-4/Nerve Growth Factor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Optical character recognition reading aid for the visually impaired.
Next Document:  Ultrastructure of rat seminal vesicle epithelium in the acute phase of spinal cord transection.